-
Article
Open AccessmiR-378d suppresses malignant phenotype of ESCC cells through AKT signaling
Post-resistance progress in paclitaxel (PTX) treatment remains a major challenge in tumor treatment. A high dose of PTX was used for cell lines to analyze the changes in molecular expression. The miR-378d was ...
-
Article
Vimentin is a crucial target for anti-metastasis therapy of nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is a unique subtype of head and neck cancer, with tendency to spread to regional lymph nodes and distant organs at early stage. Vimentin, a major cytoskeletal protein constituent...
-
Article
Open AccessAdult metanephric adenoma presumed to be all benign? A clinical perspective
In most documented literature, metanephric adenoma (MA) is described as a benign tumour. Nevertheless, the nature of MA remains unclear and the clinical criteria of different MA subtypes are not well establish...